Publications by authors named "Denis Getsios"

Claim this Profile
M
Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study.
Jean Ferrières, Jean Dallongeville, Michel Rossignol, Jacques Bénichou, J Jaime Caro, Denis Getsios

J Clin Lipidol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.
Catherine Saint-Laurent Thibault, Ipek Özer Stillman, Stephanie Chen, Denis Getsios, Irina Proskorovsky

J Med Econ· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.
Luis Hernandez, Asli Ozen, Rodrigo DosSantos, Denis Getsios

Pharmacoeconomics· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating disease-modifying agents: a simulation framework for Alzheimer's disease.
Shien Guo, Denis Getsios, Nikhil Revankar, Peng Xu, Gwilym Thompson

Pharmacoeconomics· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysis.
Thitima Kongnakorn, James A Sterchele, Christopher G Salvador, Denis Getsios, Mkaya Mwamburi

Clinicoecon Outcomes Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventions.
Denis Getsios, Jenő P Marton, Nikhil Revankar, Alexandra J Ward, Richard J Willke

Pharmacoeconomics· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved perioperative blood pressure control leads to reduced hospital costs.
Denis Getsios, Yamei Wang, Marilyn Stolar, Greg Williams, K Jack Ishak

Expert Opin Pharmacother· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Florbetaben PET in the Early Diagnosis of Alzheimer's Disease: A Discrete Event Simulation to Explore Its Potential Value and Key Data Gaps.
Shien Guo, Denis Getsios, Luis Hernandez, Kelly Cho, Elizabeth Lawler

Int J Alzheimers Dis· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accounting for the relationship between per diem cost and LOS when estimating hospitalization costs.
K Jack Ishak, Marilyn Stolar, Ming-yi Hu, Piedad Alvarez, Yamei Wang, Denis Getsios

BMC Health Serv Res· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inclusion of compliance and persistence in economic models: past, present and future.
Ananth Kadambi, Robert J Leipold, Anuraag R Kansal, Sonja Sorensen, Denis Getsios

Appl Health Econ Health Policy· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the cost effectiveness of donepezil in the treatment of Alzheimer's disease in Germany using discrete event simulation.
Susanne Hartz, Denis Getsios, Sunning Tao, Steve Blume, Grant Maclaine

BMC Neurol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer's disease: a UK evaluation using discrete-event simulation.
Denis Getsios, Steve Blume, K Jack Ishak, Grant D H Maclaine

Pharmacoeconomics· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discrete event simulation: the preferred technique for health economic evaluations?
Jaime J Caro, Jörgen Möller, Denis Getsios

Value Health· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underestimation of invasive meningococcal disease case fatality rates.
Pascal Crépey, Denis Getsios

Clin Infect Dis· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects.
Laurent Coudeville, Annelies Van Rie, Denis Getsios, J Jaime Caro, Pascal Crépey

PLoS One· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NICE cost-effectiveness appraisal of cholinesterase inhibitors: was the right question posed? Were the best tools used?
Denis Getsios, Kristen Migliaccio-Walle, Jaime J Caro

Pharmacoeconomics· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regarding probabilistic analysis and computationally expensive models: necessary and required?
J Jaime Caro, Denis Getsios, Jörgen Möller

Value Health· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
J Jaime Caro, Jörgen Möller, Denis Getsios, L Coudeville, Wissam El-Hadi

BMC Public Health· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing meningococcal disease in the United States: Hospital case characteristics and costs by age.
Judith A O'Brien, J Jaime Caro, Denis Getsios

Value Health· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.
Denis Getsios, Wissam El-Hadi, Ingrid Caro, J Jaime Caro

Pharmacoeconomics· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertussis in adolescents and adults: should we accept the results?
Jaime Caro, Getsios Denis, Laurent Coudeville, Annelies Van Rie

Pediatrics· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries.
Jaime Caro, Maribel Salas, Alexandra Ward, Denis Getsios, Kristen Migliaccio-Walle

Drugs Aging· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of pertussis and the impact of immunization.
J Jaime Caro, Denis Getsios, Krista Payne, Lieven Annemans, Peter J Neumann

Pediatr Infect Dis J· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertussis immunization of adolescents in the United States: an economic evaluation.
J Jaime Caro, Denis Getsios, Wissam El-Hadi, Krista Payne, Judith A O'Brien

Pediatr Infect Dis J· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the economics of vaccination for Neisseria meningitidis in industrialized nations: a review and recommendations for further research.
Denis Getsios, Ingrid Caro, Wissam El-Hadi, Jaime J Caro

Int J Technol Assess Health Care· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis